DAS28

Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study
Polina Putrik, Sofia Ramiro, Andras P Keszei, Ihsane Hmamouchi, Maxime Dougados, Till Uhlig, Tore K Kvien, Annelies Boonen

Annals of the Rheumatic Diseases Mar 2016, 75 (3) 540-546; DOI: 10.1136/annrheumdis-2014-206737
The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapy
Tina M Backhaus, Sarah Ohrndorf, Herbert Kellner, Johannes Strunk, Wolfgang Hartung, Horst Sattler, Christof Iking-Konert, Gerd R Burmester, Wolfgang A Schmidt, Marina Backhaus

Annals of the Rheumatic Diseases Jul 2013, 72 (7) 1163-1169; DOI: 10.1136/annrheumdis-2012-201397
Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis
Katja Thiele, Dörte Huscher, Sascha Bischoff, Susanna Späthling-Mestekemper, Marina Backhaus, Martin Aringer, Thomas Kohlmann, Angela Zink, for the German Collaborative Arthritis Centres

Annals of the Rheumatic Diseases Jul 2013, 72 (7) 1194-1199; DOI: 10.1136/annrheumdis-2012-201821
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)
R Westhovens, P C Taylor, R Alten, D Pavlova, F Enríquez-Sosa, M Mazur, M Greenwald, A Van der Aa, F Vanhoutte, C Tasset, P Harrison

Annals of the Rheumatic Diseases Jun 2017, 76 (6) 998-1008; DOI: 10.1136/annrheumdis-2016-210104
Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate
Hiroaki Matsuno, Masato Tomomitsu, Atsushi Hagino, Seonghye Shin, Jiyoon Lee, Yeong Wook Song

Annals of the Rheumatic Diseases Apr 2018, 77 (4) 488-494; DOI: 10.1136/annrheumdis-2017-212172
Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis
Sophie Henaux, Adeline Ruyssen-Witrand, Alain Cantagrel, Thomas Barnetche, Bruno Fautrel, Nathalie Filippi, Cédric Lukas, Bernd Raffeiner, Maurizio Rossini, Yannick Degboé, Arnaud Constantin

Annals of the Rheumatic Diseases Apr 2018, 77 (4) 515-522; DOI: 10.1136/annrheumdis-2017-212423
Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)
Peter Nash, Kamal Ohson, Jessica Walsh, Nikolay Delev, Dianne Nguyen, Lichen Teng, Juan J Gómez-Reino, Jacob A Aelion

Annals of the Rheumatic Diseases May 2018, 77 (5) 690-698; DOI: 10.1136/annrheumdis-2017-211568
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up
Vivek Anand Manivel, Mohammed Mullazehi, Leonid Padyukov, Helga Westerlind, Lars Klareskog, Lars Alfredsson, Saedis Saevarsdottir, Johan Rönnelid

Annals of the Rheumatic Diseases Sep 2017, 76 (9) 1529-1536; DOI: 10.1136/annrheumdis-2016-210873
Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis
Qiong Wu, Hema Chaplin, Nicola Ambrose, Debajit Sen, Maria J Leandro, Charlotte Wing, Nicola Daly, Kate Webb, Corinne Fisher, Linda Suffield, Francesca Josephs, Clarissa Pilkington, Despina Eleftheriou, Muthana Al-Obaidi, Sandrine Compeyrot-Lacassagne, Lucy R Wedderburn, Yiannis Ioannou

Annals of the Rheumatic Diseases Mar 2016, 75 (3) 635-636; DOI: 10.1136/annrheumdis-2015-208462
Is there a need for new thresholds to define remission and low disease activity by Disease Activity Score 28 calculated with C reactive protein? Real life data from a local registry
Ennio Giulio Favalli, Andrea Becciolini, Martina Biggioggero, Antonio Marchesoni, Pier Luigi Meroni

Annals of the Rheumatic Diseases Jan 2015, 74 (1) e5; DOI: 10.1136/annrheumdis-2014-206651

Main menu

DAS28

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

DAS28

Pages